BOOST-ON
LIVE

Serial Number

79453265

Owner

Arthex Biotech S.L.

Filing Date

May 8, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BOOST-ON Trademark

Serial Number: 79453265

BOOST-ON is a trademark filed by Arthex Biotech S.L. on May 8, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Arthex Biotech S.L. (5 trademarks)

Calle catedrático Agustín Escardino, 9

Entity Type: 99

Trademark Details

Filing Date

May 8, 2026

Registration Date

Not Registered

Goods & Services

Medical and pharmacological research services; research and development services relating to medical preparations; information on medical and scientific research of pharmaceuticals and clinical trials; providing medical research information in the field of pharmaceutical products; development of pharmaceutical products; research relating to pharmaceutical products; clinical studies for pharmaceutical products; development of pharmaceutical preparations and medicines; consultancy relating to pharmacogenetics research; research and development in the field of pharmacy and biotechnology; research and development for the pharmaceutical industry; technical research in the field of pharmaceutical studies; laboratory research services relating to pharmaceutical products; scientific research in the field of pharmacy; conducting early evaluations in relation to new pharmaceutical products; pharmaceutical product efficacy assessment services; computer platform development.

Pharmaceutical products; medical products; veterinary products and substances; medicines; drugs; pharmaceutical preparations; chemical products for pharmaceutical purposes; agents for administering medicines.

Chemical substances for use in the production of drugs; chemical preparations for use in the manufacture of drugs; chemical products used for the manufacture of drugs.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 2, 2026 REPR